Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of 99mTc-glucarate to Detect Acute Coronary Syndrome in Chest Pain Patients.

This study has been completed.
Sponsor:
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI)
Yale University
University of Pittsburgh
University of Alabama at Birmingham
University Hospitals Cleveland Medical Center
Information provided by (Responsible Party):
Molecular Targeting Technologies, Inc.
ClinicalTrials.gov Identifier:
NCT00614354
First received: January 30, 2008
Last updated: October 23, 2013
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2010
  Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)